Viking Therapeutics Newsroom

Eli Lilly and Co (LLY.US) explores new uses for 'weight-loss miracle drug' Zepbound, aiming to reduce the incidence of high-risk populations such as diabetes.

eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.

Zhitong FinanceOct 2 15:57

Lilly Looking to Test Zepbound as Health Maintenance Drug: Report

Seeking AlphaOct 1 22:22

New Small-cap Buy and Sell Ideas for Oppenheimer's 50/50 List

Seeking AlphaOct 1 00:34

Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report

Seeking AlphaSep 30 23:25

Morgan Stanley Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $105

Futu NewsSep 30 17:33 · Ratings

$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today

BenzingaSep 28 00:30

Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024?

Yahoo FinanceSep 27 08:22

Oppenheimer points out the next "trend" in weight loss drugs: oral over-the-counter medications.

The competition to develop oral weight loss drugs is heating up.

Zhitong FinanceSep 26 10:38

Why Viking Therapeutics Stock Was So Healthy on Wednesday

Yahoo FinanceSep 26 06:08

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Yahoo FinanceSep 26 05:50

Next Frontier in Anti-obesity Landscape: Oral GLP-1s With Potential OTC Switch

Seeking AlphaSep 26 02:55

Viking Therapeutics Analyst Ratings

BenzingaSep 26 01:49 · Ratings

Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $138

Futu NewsSep 26 00:31 · Ratings

Viking Therapeutics Unusual Options Activity For September 24

BenzingaSep 24 23:16

Weight loss candidate drug nimacimab safety approved. Skye (SKYE.US) stock price soared 11%.

Skye Bioscience's stock price soared 11%, benefiting from the safety differences between its weight loss candidate drug nimacimab and novo-nordisk a/s's monlunabant.

Zhitong FinanceSep 24 15:26

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaSep 24 01:35

Skye Stock Rallies 22% Following Weight-loss Drug Update

Seeking AlphaSep 24 00:27

Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers' Target?

Yahoo FinanceSep 21 22:39

Viking Therapeutics(VKTX.US) Officer Sells US$15.31 Million in Common Stock

$Viking Therapeutics(VKTX.US)$ Officer Lian Brian sold 216.13K shares of common stock on Sep 20, 2024 at an average price of $70.8303 for a total value of $15.31 million.Source: Announcement What is

Futu NewsSep 21 09:24

Viking Therapeutics CEO Sells Over $15m in Company Stock

InvestingSep 21 09:24